Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AAPB vs GNPX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AAPB Captures Overall Composite Edge (52.4 HOLD vs 42.2 HOLD), While GNPX Leads 2–1 on Growth & Valuation Pillars

AAPB Overall Winner 6-Pillar Tally: AAPB 1 – 2 GNPX (3 Tie) Matrix Metrics: AAPB 3 – 5 GNPX

As of Nov 20, 2026, GraniteShares ETF Trust GraniteShares 2x Long AAPL Daily ETF (AAPB) captures the overall head-to-head institutional edge over Genprex, Inc. (GNPX) on higher Unified Composite conviction (52.4/100 HOLD vs. 42.2/100 HOLD) after splitting the core matrix 3–5 (led by Balance Sheet & Cash Flow), while GNPX wins 2–1 across the 6-pillar growth and valuation breakdown. AAPB trades at $44.98 (N/M Forward P/E, N/A operating margin) versus GNPX at $1.45 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: AAPB earns the overall head-to-head edge with a stronger Unified Composite Score (52.4/100 HOLD vs. GNPX 42.2/100 HOLD) and 1.01β · 52% Vol risk profile, whereas GNPX leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AAPB trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.1); meanwhile GNPX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AAPB vs GNPX
AAPB NASDAQ Head-to-Head Winner
GraniteShares ETF Trust GraniteShares 2x Long AAPL Daily ETF
Institutional Equity
$44.98
-4.11% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.01β · 52% Vol
Unified Composite Score
52.4 / 100 HOLD
Tech 39.0 Fund 43.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.1 · SMA20: $46.60 · SMA50: $45.46
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -4.68β · 96% Vol
Unified Composite Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -22.2%), weak momentum, RSI 27
RSI-14: 26.6 · SMA20: $2.00 · SMA50: $2.48

6-Pillar Scorecard Institutional Category Breakdown (AAPB 1 – 2 GNPX)

Columns: Metric · AAPB · GNPX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale GNPX
Revenue Growth (YoY) N/A +0.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A N/A
Market Cap N/A $2.2M
3. Profitability & Quality GNPX
Gross Margin N/A N/A
Operating Margin N/A 0.0%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -233.7%
4. Balance Sheet & Cash Flow AAPB
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $11.26 Book/Sh · -233.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 41.5% (26th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AAPB (3) vs GNPX (5)
Institutional Metric AAPB GNPX Criterion Row Edge
Market Capitalization
Scale
N/A $2.2M Larger Scale GNPX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +0.0% Higher Growth GNPX
Operating Margin (TTM)
Profitability
N/A 0.0% Higher Margin GNPX
Net Profit Margin
Profitability
N/A 0.0% Higher Margin GNPX
Return on Equity (ROE)
Capital Efficiency
N/A -233.7% Higher ROE GNPX
52-Week Range Position
Momentum
79% ($25–$50) 11% ($0–$10) Stronger Trend AAPB
Beta / 30D Volatility
Risk Regime
1.01β · 52% Vol -4.68β · 96% Vol Lower Realized Risk AAPB
Unified Institutional Score
Composite Signal
52.4 / 100 (HOLD) 42.2 / 100 (HOLD) Higher Composite AAPB
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A ($11.26 Book/Sh · -233.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AAPB +22.14 pp
AAPB: -4.63% · GNPX: -26.77%
3M Horizon AAPB +81.8 pp
AAPB: +17.87% · GNPX: -63.93%
6M Horizon GNPX +62.65 pp
AAPB: +13.94% · GNPX: +76.59%
1Y Horizon AAPB +93.61 pp
AAPB: +37.02% · GNPX: -56.59%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAPB vs GNPX. Trailing 12-month operating profitability (AAPB N/A vs GNPX 0.0%) and valuation multiples (AAPB N/M vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AAPB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
GNPX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-233.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AAPB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 41.5%
IV Percentile 26th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AAPB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GNPX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GNPX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AAPB Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
GNPX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AAPB vs GNPX Key Questions & Quantitative Answers

As of Nov 20, 2026, GraniteShares ETF Trust GraniteShares 2x Long AAPL Daily ETF (AAPB) captures the overall head-to-head institutional edge over Genprex, Inc. (GNPX) on higher Unified Composite conviction (52.4/100 HOLD vs. 42.2/100 HOLD) after splitting the core matrix 3–5 (led by Balance Sheet & Cash Flow), while GNPX wins 2–1 across the 6-pillar growth and valuation breakdown. AAPB trades at $44.98 (N/M Forward P/E, N/A operating margin) versus GNPX at $1.45 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: AAPB earns the overall head-to-head edge with a stronger Unified Composite Score (52.4/100 HOLD vs. GNPX 42.2/100 HOLD) and 1.01β · 52% Vol risk profile, whereas GNPX leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AAPB trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.1); meanwhile GNPX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GNPX leads the Growth & Scale pillar: AAPB posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with GNPX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, AAPB generates N/A in USD-normalized revenue versus N/A for GNPX. In operating R&D and SG&A reinvestment, AAPB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GNPX.

AAPB and GNPX trade at balanced relative valuation multiples. AAPB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas GNPX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AAPB (N/A ROE) versus GNPX (-233.7% ROE) capital efficiency.

In options market volatility and institutional positioning, AAPB carries 41.5% implied volatility (26th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.01β · 52% Vol realized risk). By comparison, GNPX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-4.68β · 96% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.